Skip to content

Alere I Strep a

by Alere Scarborough, Inc.

510(k) K141757

Alere I Strep a is a medical device (FDA Class II; FDA product code PGX, Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System) made by Alere Scarborough, Inc., cleared under FDA 510(k) K141757 on 31 Mar 2015, active as of 10 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 10 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 10 Oct 2026.

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK141757 Date31 Mar 2015ClearedStatusActive

Official records

From the FDA record

Received by the FDA
30 Jun 2014
FDA decision
31 Mar 2015 (Substantially Equivalent)
FDA review time
274 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K141757 (openFDA), as read on 10 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
PGX
Device class
Class II
Regulation
21 CFR Part 866.2680
Advisory committee
Microbiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System).

Other devices from Alere Scarborough, Inc.

See all devices from Alere Scarborough, Inc. →